ISMCS 2024 - Free Paper Presentation
*
= Required
After inputting required data, press the confirmation button to proceed.
PERSONAL INFORMATION
Title
*
Prof
Dr
Mr
Ms
Name
*
First Name
Last Name
Department
*
Institution
*
Mailing Address
*
Tel (office hours)
*
Mobile
E-mail Address
*
Verify E-mail Address
*
Password for this submission data
*
Password length must be 6 - 8 alphanumeric characters.
**Please make sure not to forget your password. For security reasons, your password will not be written in the confirmation email.
Reenter password
*
First author's institution(s) number
*
Please check the number(s) to indicate the first author's institutions(s).
1
2
3
4
5
6
7
8
9
10
*These numbers correspond to the numbers on this list of institutions below.
Institution(s) of the first author
*
Please input one institution of the first author
(e.g.: Department of cardiovascular surgey,Dokkyo Medical University SaiTama Medical Center)
Please input institution(s) of the first author and Coauthors if there are any except you entered as the first author's institution above.
Institution 2
Institution 3
Institution 4
Institution 5
Institution 6
Institution 7
Institution 8
Institution 9
Institution 10
Please input followings if there are any Coauthors;
Coauthor 2
First Name
Last Name
Institution number of Coauthor 2
1
2
3
4
5
6
7
8
9
10
Coauthor 3
First Name
Last Name
Institution number of Coauthor 3
1
2
3
4
5
6
7
8
9
10
Coauthor 4
First Name
Last Name
Institution number of Coauthor 4
1
2
3
4
5
6
7
8
9
10
Coauthor 5
First Name
Last Name
Institution number of Coauthor 5
1
2
3
4
5
6
7
8
9
10
Coauthor 6
First Name
Last Name
Institution number of Coauthor 6
1
2
3
4
5
6
7
8
9
10
Coauthor 7
First Name
Last Name
Institution number of Coauthor 7
1
2
3
4
5
6
7
8
9
10
Coauthor 8
First Name
Last Name
Institution number of Coauthor 8
1
2
3
4
5
6
7
8
9
10
Coauthor 9
First Name
Last Name
Institution number of Coauthor 9
1
2
3
4
5
6
7
8
9
10
Coauthor 10
First Name
Last Name
Institution number of Coauthor 10
1
2
3
4
5
6
7
8
9
10
Coauthor 11
First Name
Last Name
Institution number of Coauthor 11
1
2
3
4
5
6
7
8
9
10
Coauthor 12
First Name
Last Name
Institution number of Coauthor 12
1
2
3
4
5
6
7
8
9
10
Coauthor 13
First Name
Last Name
Institution number of Coauthor 13
1
2
3
4
5
6
7
8
9
10
Coauthor 14
First Name
Last Name
Institution number of Coauthor 14
1
2
3
4
5
6
7
8
9
10
Coauthor 15
First Name
Last Name
Institution number of Coauthor 15
1
2
3
4
5
6
7
8
9
10
Coauthor 16
First Name
Last Name
Institution number of Coauthor 16
1
2
3
4
5
6
7
8
9
10
Coauthor 17
First Name
Last Name
Institution number of Coauthor 17
1
2
3
4
5
6
7
8
9
10
Coauthor 18
First Name
Last Name
Institution number of Coauthor 18
1
2
3
4
5
6
7
8
9
10
Coauthor 19
First Name
Last Name
Institution number of Coauthor 19
1
2
3
4
5
6
7
8
9
10
Coauthor 20
First Name
Last Name
Institution number of Coauthor 20
1
2
3
4
5
6
7
8
9
10
PRESENTATION STYLE
*
Please select one style from below:
Oral
Poster
SUBMISSION TOPICS
*
Please select one topic from below:
01. Joint symposium 1 (ISMCS - Heart Failure Cardiologist joint symposium)
02. Joint symposium 2 (ISMCS-Asian-Pacific ELSO joint symposium)
03. Joint symposium 3 (DCD transplantation：is it really good? ISMCS-Japanese Society for Heart transplantation joint symp)
04. Joint symposium 4 (VAD coordinator session Caregiver is still necessary?)
05. Joint symposium 5 (ISMCS-JSAO joint symposium How to design new pumps(digital twins，virtual fitting，In silico testing…))
06. Temporary MCS 1 (Oral or Poster)(Risk Stratification of shock patients requiring t-MCS)
07. Temporary MCS 2 (Oral or Poster)(New technology in percutaneous MCS Impella and others)
08. Temporary MCS 3 (Oral or Poster)(Impella for high risk surgery：Preoperative or postoperative support?)
09. Temporary MCS 4 (Oral or Poster)(Managing bleeding during MCS)
10. Temporary MCS 5 (Oral or Poster)(t-MCS around the Globe (national database，registry data))
11. Temporary MCS 6 (Oral or Poster)(How can we safely and effectively mobilize patients on t-MCS in ICU?)
12. Temporary MCS 7 (Oral or Poster)(Role of inhaled nitric oxide in patients with MCS)
13. Temporary MCS 8 (Oral or Poster)(What is important in ECPR，O2，temperature，or ventricular unloading?)
14. Temporary MCS 9 (Oral or Poster)(Role of monitoring in t-MCS)
15. Durable MCS 1 (Oral or Poster)(Booming VAD therapy in Asian countries)
16. Durable MCS 2 (Oral or Poster)(HM3 in registry data around the globe)
17. Durable MCS 3 (Oral or Poster)(Remote monitoring / AI for LVAD patients care CardioMEMS HF System and others)
18. Durable MCS 4 (Oral or Poster)(Cardiac recovery after MCS (medication，rehabilitation，and cell therapy))
19. Durable MCS 5 (Oral or Poster)(VAD for small patients (BSA<1.5))
20. Durable MCS 6 (Oral or Poster)(VAD for congenital heart disease)
21. Durable MCS 7 (Oral or Poster)(VAD exchange：how we do it)
22. Durable MCS 8 (Oral or Poster)(MICS-LVAD implantation：tricks and pitfalls)
23. Durable MCS 9 (Oral or Poster)(TAH or two implantable VAD?)
24. Durable MCS 10 (Oral or Poster)(Valve surgery for VAD patients：stitch/patch/SAVR/TAVR)
25. Durable MCS 11 (Oral or Poster)(What is new? New device and idea from laboratory)
26. Durable MCS 12 (Oral or Poster)(Cost effectiveness issue in MCS)
27. Durable MCS 13 (Oral or Poster)(Is Pulse necessary in human?)
28. Durable MCS 14 (Oral or Poster)(Challenge for diastolic dysfunction (HFpEF)：new device? new technique?)
29. Durable MCS 15 (Oral or Poster)(Quality of life of VAD patients：Moving from forgiving device to forgettable one)
30. Durable MCS 16 (Oral or Poster)(My nightmare case：how we survived)
31. Others (oral/poster)
TITLE OF PRESENTATION
*
(Maximum 200 words)
Remark: Final presentation style will be subject to the decision of the Scientific Committee.
ABSTRACT BODY
*
(Maximum 2000 words)
・For graph, please press the confirmation button below and add graph on the next page.